XFOR Stock Analysis: Buy, Sell, or Hold?
XFOR - X4 Pharmaceuticals, Inc. Common Stock
$4.22
-0.13 (-2.99%)
▼
5d:
-2.09%
30d:
+20.57%
90d:
+5.5%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When XFOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XFOR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: XFOR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: XFOR is currently trading at $4.22, which is considered slightly high relative to its 30-day fair value range of $3.49 to $4.26.
Technical Outlook: Technically, XFOR is showing sideways momentum. Immediate support is located at $3.81, while resistance sits at $4.51.
Market Sentiment: XFOR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.67 (+168.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XFOR is showing sideways momentum. Immediate support is located at $3.81, while resistance sits at $4.51.
Market Sentiment: XFOR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.67 (+168.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$3.49 -
$4.26
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 168.2% below Wall St target ($11.67)
Fair Price Analysis
30-Day Fair Range
$3.49 -
$4.26
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.81
Resistance Level
$4.51
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.51
Wall Street Target
$11.67
(+168.2%)
Revenue Growth (YoY)
79.1%
Profit Margin
-225.6%
Share & Embed Analysis
Last updated: April 02, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XFOR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Adam R Craig
BUY
86206 shares
2025-10-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
